Advertisement

Ionic Equilibria and the pH Dependence of Solubility

  • HARRY G. BRITTAIN
Part of the Biotechnology: Pharmaceutical Aspects book series (PHARMASP, volume VI)

Abstract

Many drug substances can be classified as being either acids or bases in that they possess the ability to react with other acids or bases that are stronger than themselves. As such, they would also possess the ability to exist as ionic species under certain conditions. The state of ionization of a substance will often profoundly affect its degree of aqueous solubility, as evidenced by the high solubility of sodium benzoate as opposed to the low solubility of benzoic acid. The utility of salt forms as active pharmaceutical ingredients is well known, and represents one of the means to increase the degree of solubility of an otherwise intractable substance (Berge et al. 1977; Stahl and Wermuth 2002).

Keywords

Weak Acid Free Acid Aqueous Solubility Drug Substance Ionic Equilibrium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akers MJ. Excipient-Drug Interactions in Parenteral Formulations. J Pharm Sci 2002; 91: 2283–2300.PubMedCrossRefGoogle Scholar
  2. Avdeef A. pH-metric solubility. 1. solubility-pH profiles from Bjerrum plots. Gibbs buffer and pKa in the solid state. Pharm Pharmacol Commun 1998; 4: 165–178.Google Scholar
  3. Avdeef A and Berger CM. pH-metric solubility. 3. Dissolution titration template method for solubility determination. Eur J Pharm Sci 2001; 14: 281–291.PubMedCrossRefGoogle Scholar
  4. Avdeef A, Berger CM, and Brownell C. pH-metric solubility. 2. Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods. Pharm Res 2000; 17: 85–89.PubMedCrossRefGoogle Scholar
  5. Berge SM, Bighley LD, and Monkhouse DC. Pharmaceutical Salts. J Pharm Sci 1977; 66: 1–19.PubMedCrossRefGoogle Scholar
  6. Bogardus JB and Blackwood RK. Solubility of doxycycline in aqueous solution. J Pharm Sci 1979; 68: 188–194.PubMedCrossRefGoogle Scholar
  7. Boylan JC. Liquids. In: Lachman L, Lieberman HA, and Kanig J (eds.), The Theory and Practice of Industrial Pharmacy. Lea & Febiger, Philadelphia, PA, 1986, pp. 459–460.Google Scholar
  8. Dean JA Lange's Handbook of Chemistry, 12th edition. McGraw-Hill, New York, NY, 1979, pp. 5–7.Google Scholar
  9. Freiser H and Fernando Q. Ionic Equilibria in Analytical Chemistry. John Wiley & Sons, New York, NY, 1963, p. 334.Google Scholar
  10. Granero G, de Bertorello MM, and Brinon MC. Solubility profiles of some isoxazolyl-naphthoquinone derivatives. Int J Pharm 1991; 190: 41–47.CrossRefGoogle Scholar
  11. Grant DJW and Brittain HG. Solubility of Pharmaceutical Solids. In: Brittain HG (ed.), Physical Characterization of Pharmaceutical Solids. Marcel Dekker, New York, NY, 1995, pp. 321–386.Google Scholar
  12. Grant DJW and Higuchi T. Solubility Behavior of Organic Compounds. John Wiley & Sons, New York, NY, 1990, p. 600.Google Scholar
  13. Grant DJW, Mehdizadeh M, Chow AH-L, and Fairbrother JE. Non-linear van't Hoff solubility-temperature plots and their pharmaceutical interpretation. Int J Pharm 1984; 18: 25–38.CrossRefGoogle Scholar
  14. Higuchi T, Shih F-ML, Kimura T, and Rytting JH. Solubility Determination of Barely aqueous-soluble organic solids. J Pharm Sci 1979; 68: 1267–1272.PubMedCrossRefGoogle Scholar
  15. Jacques J, Collet A, and Wilen SH. Enantiomers, Racemates and Resolutions. John Wiley & Sons, New York, NY, 1981, p. 447.Google Scholar
  16. Jinno J, Oh D-M, Crison JR, and Amidon GL. Dissolution of ionizable water-insoluble drugs: The combined effect of pH and surfactant. J Pharm Sci 2000; 89: 268–274.PubMedCrossRefGoogle Scholar
  17. Kramer SF and Flynn GL. Solubility of organic hydrochlorides. J Pharm Sci 1972; 61: 1896–1904.PubMedCrossRefGoogle Scholar
  18. Li P, Tabibi SE, and Yalkowsky SH. Combined effect of complexation and pH on solubilization. J Pharm Sci 1998; 87: 1535–1537.PubMedCrossRefGoogle Scholar
  19. Li P, Tabibi SE, and Yalkowsky SH. Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants. J Pharm Sci 1999; 88: 945–947.PubMedCrossRefGoogle Scholar
  20. Li P and Zhao L. Solubilization of flurbiprofen in pH-surfactant solutions. J Pharm Sci 2003; 92: 951–956.PubMedCrossRefGoogle Scholar
  21. Mader WJ, Vold RD, and Vold MJ. Determination of solubility. In: Weissberger A (ed.), Physical Methods of Organic Chemistry, 3rd edn., Vol. 1, Part I. Interscience Publishers, New York, NY, 1959, pp. 655–688.Google Scholar
  22. Martell AE and Smith RM. Critical Stability Constants. Volume 1: Amino Acids. Plenum Press, New York, NY, 1974, p. 469.Google Scholar
  23. Martell AE and Smith RM. Critical Stability Constants. Volume 3: Other Organic Ligands. Plenum Press, New York, NY, 1977, p. 495.Google Scholar
  24. McDonald C and Faridah H. Solubilities of trimethoprim and sulfamethoxazole at various pH values and crystallization of trimethoprim from infusion fluids. J Parenteral Sci Tech 1991; 45: 147–151.Google Scholar
  25. Nema S, Washkuhn RJ, and Brendel RJ. Excipients and their use in injectable products. PDA J Pharm Sci Tech 1997; 51: 166–171.Google Scholar
  26. Pudipeddi M, Serajuddin ATM, Grant DJW, and Stahl PH. Solubility and Dissolution of Weak Acids, Bases, and Salts. In Stahl PH and Wermuth CG. Handbook of Pharmaceutical Salts. Wiley-VCH, Weinheim, Germany, 2002, pp. 19–39.Google Scholar
  27. Smith RM and Martell AE. Critical Stability Constants. Volume 2: Amines. Plenum Press, New York, NY, 1975, p. 415.Google Scholar
  28. Smith RM and Martell AE. Critical Stability Constants. Volume 4: Inorganic Complexes Amino Acids. Plenum Press, New York, NY, 1976, p. 257.Google Scholar
  29. Sørensen SPL. The measurement and importance of the hydrogen ion concentration in enzyme reactions. Biochem. Z. 1909; 21: 131–304.Google Scholar
  30. Stahl PH and Wermuth CG. Handbook of Pharmaceutical Salts. Wiley-VCH, Weinheim, Germany, 2002, p. 374.Google Scholar
  31. Streng WH, Hsi SK, Helms PE, and Tan HGH. General treatment of pH-solubility profiles of weak acids and bases and the effects of different acids on the solubility of a weak base. J Pharm Sci 1984; 73: 1679–1684.PubMedCrossRefGoogle Scholar
  32. Wang Y-CJ and Kowal RR. Review of excipients and pH's for parenteral products used in the United States. J Parenteral Drug Assoc 1980; 34: 452–462.Google Scholar
  33. Yalkowsky SH and Banerjee S. Aqueous Solubility Methods of Estimation for Organic Compounds, Marcel Dekker, New York, 1992, pp. 149–154.Google Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • HARRY G. BRITTAIN
    • 1
  1. 1.Center for Pharmaceutical PhysicsMilfordNJ

Personalised recommendations